Back

Projected impact of a national Tobacco 21 policy in the Kingdom of Saudi Arabia

Tam, J.; Meza, R.; Aljabri, M. A.; Al-Zalabani, A. H.; Monshi, S. S.; Yakoub, A. A.; Aldhaher, F. M.; Hamza, M. M.; Albalawi, W.; Alsukait, R.; Shahin, M. A.; Cetinkaya, V.; Alghaith, T.

2026-02-27 health policy
10.64898/2026.02.25.26347109 medRxiv
Show abstract

IntroductionTobacco smoking is especially high among males in the Kingdom of Saudi Arabia (KSA). In 2019, 27.5% of males ages 15+ reported smoking. Despite a minimum age requirement of 18 years, data indicate that 6.8% of youth ages 13-15 currently smoke tobacco products. To reduce youth smoking, countries have raised the minimum purchase age to 21, also referred to as Tobacco 21. Except for Kuwait, no other Middle Eastern country has done so. We develop a tobacco smoking simulation model to project the potential impact of a national Tobacco 21 policy in Saudi Arabia. MethodsWe used data from three nationally representative health surveys in Saudi Arabia to develop the KSA Tobacco Control Policy (TCP) model, estimating smoking initiation and cessation rates for males, as smoking rates are low among females. A national Tobacco 21 policy was operationalized as a 34% (15%-53%) reduction to smoking initiation for ages 18-20. Economic impact was evaluated using the 2024 KSA value of a statistical life which ranges from $1.65 million to $5.15 million USD. ResultsUnder a status quo scenario, tobacco smoking prevalence in males would decrease to 10.2% by 2100. Implementation of Tobacco 21 in 2026 would decrease smoking prevalence to 9.4% (8.9%, 9.8%) by 2100. While modest, these reductions would eventually translate into nearly 5000 (2200, 7800) premature deaths averted with up to 155000 (69000, 241000) life years gained from 2026-2100, respectively. The total expected economic benefit ranges from $1.67 to $5.19 billion USD, equivalent to 6.25 to 19.45 billion SAR. DiscussionTimely implementation would support the KSA in its goals to reduce non-communicable disease and death; however, even under best-case conditions, a Tobacco 21 alone would not achieve the Vision 2030 smoking prevalence target of 9%. Additional policies that substantially increase smoking cessation are needed. What is already known on this topicThe leading causes of death in Saudi Arabia are all linked to tobacco smoking. Tobacco 21 policies have been pursued by numerous governments to reduce youth smoking, but such policies are lacking in Middle Eastern nations. What this study addsA nationwide Tobacco 21 policy in Saudi Arabia would reduce smoking initiation, smoking prevalence, and smoking-related mortality. Overall smoking prevalence among males ages 15+ would decline, and nearly 5000 premature deaths would be averted with up to 155,000 life years gained from 2026-2100, valued at 6.25 to 19.45 billion SAR. How this study might affect research, practice or policyThis study quantified for the first time the potential long-term benefits of a Tobacco 21 policy in Saudi Arabia for the male population. A Tobacco 21 policy would benefit future generations of young people by reducing their risk for heart disease, stroke, and cancer, currently the leading causes of death in the nation. However, additional efforts are needed in addition to Tobacco 21 policies to achieve tobacco smoking reduction goals.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 9%
18.6%
2
BMC Public Health
147 papers in training set
Top 0.1%
12.3%
3
Frontiers in Public Health
140 papers in training set
Top 0.2%
10.1%
4
International Journal of Environmental Research and Public Health
124 papers in training set
Top 0.4%
9.1%
50% of probability mass above
5
Nicotine & Tobacco Research
11 papers in training set
Top 0.1%
4.3%
6
BMJ Global Health
98 papers in training set
Top 0.7%
4.3%
7
BMJ Open
554 papers in training set
Top 5%
4.3%
8
American Journal of Preventive Medicine
11 papers in training set
Top 0.1%
3.6%
9
PLOS Global Public Health
293 papers in training set
Top 2%
3.6%
10
Nicotine and Tobacco Research
13 papers in training set
Top 0.1%
2.7%
11
Scientific Reports
3102 papers in training set
Top 50%
2.1%
12
International Journal of Drug Policy
11 papers in training set
Top 0.2%
1.9%
13
JMIR Public Health and Surveillance
45 papers in training set
Top 1%
1.9%
14
JAMA Network Open
127 papers in training set
Top 2%
1.8%
15
F1000Research
79 papers in training set
Top 2%
1.7%
16
Vaccines
196 papers in training set
Top 1%
1.5%
17
Clinical Microbiology and Infection
60 papers in training set
Top 0.7%
1.5%
18
COVID
13 papers in training set
Top 0.1%
1.3%
19
Cureus
67 papers in training set
Top 4%
1.2%
20
eClinicalMedicine
55 papers in training set
Top 1%
0.9%
21
Thorax
32 papers in training set
Top 0.7%
0.9%
22
Drug and Alcohol Dependence
37 papers in training set
Top 0.5%
0.9%
23
European Journal of Public Health
20 papers in training set
Top 1%
0.6%